These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9138294)
21. IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine. Blanco HM; Lacoste MG; Eliçabe RJ; Di Genaro MS Vaccine; 2008 Dec; 26(51):6497-502. PubMed ID: 18835575 [TBL] [Abstract][Full Text] [Related]
22. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. Sing A; Tvardovskaia N; Rost D; Kirschning CJ; Wagner H; Heesemann J Int J Med Microbiol; 2003 Nov; 293(5):341-8. PubMed ID: 14695062 [TBL] [Abstract][Full Text] [Related]
23. Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice. Cai K; Zhang Y; Yang B; Chen S Vaccine; 2013 Jan; 31(2):334-40. PubMed ID: 23153438 [TBL] [Abstract][Full Text] [Related]
25. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Roggenkamp A; Geiger AM; Leitritz L; Kessler A; Heesemann J Infect Immun; 1997 Feb; 65(2):446-51. PubMed ID: 9009295 [TBL] [Abstract][Full Text] [Related]
26. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Autenrieth IB; Beer M; Bohn E; Kaufmann SH; Heesemann J Infect Immun; 1994 Jun; 62(6):2590-9. PubMed ID: 8188382 [TBL] [Abstract][Full Text] [Related]
27. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice. Singh AK; Kingston JJ; Murali HS; Batra HV Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353 [TBL] [Abstract][Full Text] [Related]
28. Expression in vivo of additional plasmid-mediated proteins during intestinal infection with Yersinia enterocolitica serotype O8. Naumann M; Hanski C; Riecken EO J Med Microbiol; 1991 Nov; 35(5):257-63. PubMed ID: 1941997 [TBL] [Abstract][Full Text] [Related]
29. Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Handley SA; Dube PH; Revell PA; Miller VL Infect Immun; 2004 Mar; 72(3):1645-56. PubMed ID: 14977972 [TBL] [Abstract][Full Text] [Related]
30. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Nakajima R; Brubaker RR Infect Immun; 1993 Jan; 61(1):23-31. PubMed ID: 8418045 [TBL] [Abstract][Full Text] [Related]
31. Yersinia enterocolitica infection in resistant and susceptible strains of mice. Hancock GE; Schaedler RW; MacDonald TT Infect Immun; 1986 Jul; 53(1):26-31. PubMed ID: 3721579 [TBL] [Abstract][Full Text] [Related]
32. Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Bohn E; Heesemann J; Ehlers S; Autenrieth IB Infect Immun; 1994 Jul; 62(7):3027-32. PubMed ID: 8005693 [TBL] [Abstract][Full Text] [Related]
33. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity. Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162 [TBL] [Abstract][Full Text] [Related]
34. General and specific host responses to bacterial infection in Peyer's patches: a role for stromelysin-1 (matrix metalloproteinase-3) during Salmonella enterica infection. Handley SA; Miller VL Mol Microbiol; 2007 Apr; 64(1):94-110. PubMed ID: 17376075 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the cytokine immune response to pathogenic Yersinia enterocolitica bioserotype 1B/O:8 and 2/O:9 in susceptible BALB/C and resistant C57BL/6 mice. Wang X; Gu W; Qiu H; Xia S; Zheng H; Xiao Y; Liang J; Jing H Mol Immunol; 2013 Oct; 55(3-4):365-71. PubMed ID: 23582306 [TBL] [Abstract][Full Text] [Related]
36. Chromosome-mediated resistance of Yersinia enterocolitica serotype O9 to intracellular killing by mouse peritoneal macrophages. Ruiz-Bravo A; Jimenez-Valera M; Sampedro A; Moreno E FEMS Immunol Med Microbiol; 1994 Oct; 9(4):317-24. PubMed ID: 7866353 [TBL] [Abstract][Full Text] [Related]
37. Transcriptional and translational regulation of IL-1 alpha and IL-1 beta account for the control of IL-1 in experimental yersiniosis. Rausch UP; Jordan M; Rödel F; Aigner T; Otterness IG; Beuscher N; Röllinghoff M; Beuscher HU Cytokine; 1994 Sep; 6(5):504-11. PubMed ID: 7827288 [TBL] [Abstract][Full Text] [Related]
38. Increased susceptibility to Yersinia enterocolitica Infection of Tff2 deficient mice. Shah AA; Mihalj M; Ratkay I; Lubka-Pathak M; Balogh P; Klingel K; Bohn E; Blin N; Baus-Loncar M Cell Physiol Biochem; 2012; 30(4):853-62. PubMed ID: 22907484 [TBL] [Abstract][Full Text] [Related]
39. Humoral and cellular defense against intestinal murine infection with Yersinia enterocolitica. Hanski C; Naumann M; Grützkau A; Pluschke G; Friedrich B; Hahn H; Riecken EO Infect Immun; 1991 Mar; 59(3):1106-11. PubMed ID: 1997413 [TBL] [Abstract][Full Text] [Related]
40. Histamine signaling through the H(2) receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Handley SA; Dube PH; Miller VL Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9268-73. PubMed ID: 16717182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]